Conmed (CNMD) Accumulated Expenses (2010 - 2026)

Conmed (CNMD) has 17 years of Accumulated Expenses data on file, last reported at $70.4 million in Q2 2026.

• Quarterly Accumulated Expenses rose 3.63% year-over-year to $70.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $70.4 million (up 3.63% YoY) and the FY2025 annual result came in at $82.1 million, up 25.66% from the prior year.
• Accumulated Expenses climbed to $70.4 million in Q2 2026, from $60.9 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $82.1 million in Q4 2025 to a low of $45.4 million in Q1 2022.
• A 5-year average of $60.4 million and a median of $59.0 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses retreated 9.51% — and 2023, when it gained 28.02%.
• Tracing CNMD's Accumulated Expenses over 5 years: stood at $54.7 million in 2022, then grew by 28.02% to $70.1 million in 2023, then declined by 6.71% to $65.4 million in 2024, then increased by 25.66% to $82.1 million in 2025, then retreated by 14.27% to $70.4 million in 2026.
• The last three Accumulated Expenses figures came in at $70.4 million (Q2 2026), $60.9 million (Q1 2026), and $82.1 million (Q4 2025), per Business Quant data.